Cargando…
Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients
PURPOSE: Vaccination against Streptococcus pneumoniae is recommended in transplant recipients to reduce the morbidity and mortality from invasive pneumococcal disease. Previous studies indicate that transplant recipients can produce specific antibodies after vaccination with the 13-valent pneumococc...
Autores principales: | Mülling, Nils, van de Sand, Lukas, Völk, Kim, Aufderhorst, Ulrich Wilhelm, van der Linden, Mark, Horn, Peter A., Kribben, Andreas, Wilde, Benjamin, Krawczyk, Adalbert, Witzke, Oliver, Lindemann, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665231/ https://www.ncbi.nlm.nih.gov/pubmed/37243960 http://dx.doi.org/10.1007/s15010-023-02054-3 |
Ejemplares similares
-
Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years
por: Chilson, Erica, et al.
Publicado: (2017) -
Establishment of an ELISpot Assay to Detect Cellular Immunity against S. pneumoniae in Vaccinated Kidney Transplant Recipients
por: Gäckler, Anja, et al.
Publicado: (2021) -
1098 The Immunogenicity of PCV13 compared to PPSV23 in Immunocompetent Older Adults with Stable High Risk Conditions
por: Schmoele-Thoma, Beate, et al.
Publicado: (2014) -
Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2022) -
Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation
por: Lindemann, Monika, et al.
Publicado: (2021)